Discrepancies in cancer drug funding decisions found across high-income countries despite similar assessment criteria
Despite the use of similar assessment criteria when deciding whether new cancer drugs should receive funding, there are substantial differences in drug funding decisions, across comparable high-income countries.
Jun 1, 2023
0
5